Cogent Biosciences (COGT) Other Accumulated Expenses (2017 - 2026)
Cogent Biosciences' Other Accumulated Expenses came in at $1.32 million for Q2 2026, up 3.5% from $1.27 million a year earlier but down 28.6% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Cogent Biosciences' Other Accumulated Expenses was $6.75 million.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 85.5% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $373,000 in FY2024 (-15.4%), $441,000 in FY2023 (+9.2%), $404,000 in FY2022 (+71.9%) and $235,000 in FY2021 (-23.5%).
- The five-year range for quarterly Other Accumulated Expenses is $225,000 (Q3 2021) to $6.75 million (Q4 2025).
- Year-over-year, Other Accumulated Expenses increased in four of the last seven quarters, with growth averaging 133.9%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2022 (growth of 432.0%), and the weakest in Q2 2023 (a decline of 68.2%).
- Business Quant data shows COGT's Other Accumulated Expenses at $1.85 million (Q1 2026), $6.75 million (Q4 2025) and $1.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Cogent Biosciences | 5.32 Bn | 5.32 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 484,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Mar 31, 2024 | 636,000.00 |
| Dec 31, 2023 | 441,000.00 |
| Sep 30, 2023 | 458,000.00 |
| Jun 30, 2023 | 496,000.00 |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 404,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 252,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 225,000.00 |
API Access
Cogent Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();